Home›Trial›NCT07220954
🔬NCT07220954Phase 1ACTIVE NOT RECRUITING

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Study Summary

This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234. This study will take place at one site in Nottingham, United Kingdom, and will enrol 21 healthy men and women aged 18-55 years.

Conditions
Healthy Participants
Interventions / Drugs
AZD6234 Formulation 1AZD6234 Formulation 2 (low concentration)AZD6234 Formulation 2 (high concentration)AZD6234 Formulation 3
View on ClinicalTrials.gov ↗
Sponsor
AZN
AstraZeneca
Oncology/Respiratory
F15/100
Study Details
Enrollment19 participants
Primary Completion—
Lead SponsorAstraZeneca
Data Retrieved2026-04-11 02:55:19.910097+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.